PT  - JOURNAL ARTICLE
AU  - S. Vickers
AU  - E. K. Stuart
AU  - J. R. Bianchine
AU  - H. B. Hucker
AU  - M. E. Jaffe
AU  - R. E. Rhodes
AU  - W. J. A. VandenHeuvel
TI  - Metabolism of Carbidopa [L-(-)-α-Hydrazino-3,4-dihydroxy-α-methylhydrocinnamic Acid Monohydrate], an Aromatic Amino Acid Decarboxylase Inhibitor, in the Rat, Dog, Rhesus Monkey, and Man
DP  - 1974 Jul 01
TA  - Drug Metabolism and Disposition
PG  - 399--399
VI  - 2
IP  - 4
4099  - http://dmd.aspetjournals.org/content/2/4/399.1.short
4100  - http://dmd.aspetjournals.org/content/2/4/399.1.full
SO  - Drug Metab Dispos1974 Jul 01; 2
AB  - In "Metabolism of Carbidopa [L-(-)-α-Hydrazino-3,4-dihydroxy-α-methylhydrocinnamic Acid Monohydrate], an Aromatic Amino Acid Decarboxylase Inhibitor, in the Rat, Dog, Rhesus Monkey, and Man," by S. Vickers, E. K. Stuart, J. R. Bianchine, H. B. Hucker, M. E. Jaffe, R. E. Rhodes, and W. J. A. VandenHeuvel, in the January/February 1974 issue of Drug Metabolism and Disposition, vol. 2, no. 1, pp. 9-22, the second sentence of the introduction on p. 9 should read as follows (changed word in italics): It is of interest in the therapy of Parkinson's disease as a means of inhibiting the extracerebral metabolism of L-dopa and thus decreasing the dosage requirement of L-dopa and possibly, therefore, decreasing those side effects which are secondary to high levels of the amino acid in the periphery (2-5). Copyright © 1974 by The American Society for Pharmacology and Experimental Therapeutics